tolvaptan has been researched along with Oliguria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, CY; Fang, HY; Lee, WC | 1 |
| Esaki, M; Esaki, S; Esaki, Y; Hinoue, H; Iwahori, T | 1 |
2 other study(ies) available for tolvaptan and Oliguria
| Article | Year |
|---|---|
Tolvaptan rescue contrast-induced acute kidney injury: A case report.
Topics: Acute Kidney Injury; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contrast Media; Coronary Artery Disease; Female; Humans; Hyponatremia; Middle Aged; Oliguria; Percutaneous Coronary Intervention; Tolvaptan | 2018 |
Tolvaptan increases urine and ultrafiltration volume for patients with oliguria undergoing peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hypoalbuminemia; Male; Middle Aged; Nutritional Status; Oliguria; Osmolar Concentration; Peritoneal Dialysis, Continuous Ambulatory; Time Factors; Tolvaptan; Treatment Outcome; Urination; Urodynamics; Water-Electrolyte Balance | 2014 |